207 related articles for article (PubMed ID: 32765105)
1. Emerging Roles of Long Noncoding RNA Regulator of Reprogramming in Cancer Treatment.
Sun DE; Ye SY
Cancer Manag Res; 2020; 12():6103-6112. PubMed ID: 32765105
[TBL] [Abstract][Full Text] [Related]
2. Relevance Function of Linc-ROR in the Pathogenesis of Cancer.
Chen W; Yang J; Fang H; Li L; Sun J
Front Cell Dev Biol; 2020; 8():696. PubMed ID: 32850817
[TBL] [Abstract][Full Text] [Related]
3. The Emerging Roles of Long Noncoding RNA ROR (lincRNA-ROR) and its Possible Mechanisms in Human Cancers.
Pan Y; Li C; Chen J; Zhang K; Chu X; Wang R; Chen L
Cell Physiol Biochem; 2016; 40(1-2):219-229. PubMed ID: 27855392
[TBL] [Abstract][Full Text] [Related]
4. FOXM1-Mediated LINC-ROR Regulates the Proliferation and Sensitivity to Sorafenib in Hepatocellular Carcinoma.
Zhi Y; Abudoureyimu M; Zhou H; Wang T; Feng B; Wang R; Chu X
Mol Ther Nucleic Acids; 2019 Jun; 16():576-588. PubMed ID: 31082791
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA ROR promotes breast cancer by regulating the TGF-β pathway.
Hou L; Tu J; Cheng F; Yang H; Yu F; Wang M; Liu J; Fan J; Zhou G
Cancer Cell Int; 2018; 18():142. PubMed ID: 30250400
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway.
Pan Y; Chen J; Tao L; Zhang K; Wang R; Chu X; Chen L
Oncotarget; 2017 May; 8(20):33144-33158. PubMed ID: 28388536
[TBL] [Abstract][Full Text] [Related]
7. Linc-ROR and its spliced variants 2 and 4 are significantly up-regulated in esophageal squamous cell carcinoma.
Sahebi R; Malakootian M; Balalaee B; Shahryari A; Khoshnia M; Abbaszadegan MR; Moradi A; Javad Mowla S
Iran J Basic Med Sci; 2016 Oct; 19(10):1131-1135. PubMed ID: 27872710
[TBL] [Abstract][Full Text] [Related]
8. Long Non-coding RNA Linc-ROR Is Upregulated in Papillary Thyroid Carcinoma.
Zhang R; Hardin H; Huang W; Buehler D; Lloyd RV
Endocr Pathol; 2018 Mar; 29(1):1-8. PubMed ID: 29280051
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA ROR promotes radioresistance in hepatocelluar carcinoma cells by acting as a ceRNA for microRNA-145 to regulate RAD18 expression.
Chen Y; Shen Z; Zhi Y; Zhou H; Zhang K; Wang T; Feng B; Chen Y; Song H; Wang R; Chu X
Arch Biochem Biophys; 2018 May; 645():117-125. PubMed ID: 29559320
[TBL] [Abstract][Full Text] [Related]
10. Functional Relevance of the Long Intergenic Non-Coding RNA Regulator of Reprogramming (Linc-ROR) in Cancer Proliferation, Metastasis, and Drug Resistance.
Peña-Flores JA; Enríquez-Espinoza D; Muela-Campos D; Álvarez-Ramírez A; Sáenz A; Barraza-Gómez AA; Bravo K; Estrada-Macías ME; González-Alvarado K
Noncoding RNA; 2023 Jan; 9(1):. PubMed ID: 36827545
[TBL] [Abstract][Full Text] [Related]
11. Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer.
Takahashi K; Yan IK; Kogure T; Haga H; Patel T
FEBS Open Bio; 2014; 4():458-67. PubMed ID: 24918061
[TBL] [Abstract][Full Text] [Related]
12. LincRNA-ROR promotes invasion, metastasis and tumor growth in pancreatic cancer through activating ZEB1 pathway.
Zhan HX; Wang Y; Li C; Xu JW; Zhou B; Zhu JK; Han HF; Wang L; Wang YS; Hu SY
Cancer Lett; 2016 May; 374(2):261-71. PubMed ID: 26898939
[TBL] [Abstract][Full Text] [Related]
13. Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer cells.
Fu Z; Li G; Li Z; Wang Y; Zhao Y; Zheng S; Ye H; Luo Y; Zhao X; Wei L; Liu Y; Lin Q; Zhou Q; Chen R
Cell Death Discov; 2017; 3():17004. PubMed ID: 28580169
[TBL] [Abstract][Full Text] [Related]
14. Role of Long Noncoding RNA Regulator of Reprogramming in Colon Cancer Progression via Epidermal Growth Factor Receptor Signaling.
Chen Y; Yang L; Yin D; Feng X; Jie J; Yao D; Chen J
Technol Cancer Res Treat; 2022; 21():15330338221114707. PubMed ID: 35946134
[No Abstract] [Full Text] [Related]
15. Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells.
Chen YM; Liu Y; Wei HY; Lv KZ; Fu P
Tumour Biol; 2016 Aug; 37(8):10861-70. PubMed ID: 26883251
[TBL] [Abstract][Full Text] [Related]
16. Linc-ROR Promotes Osteogenic Differentiation of Mesenchymal Stem Cells by Functioning as a Competing Endogenous RNA for miR-138 and miR-145.
Feng L; Shi L; Lu YF; Wang B; Tang T; Fu WM; He W; Li G; Zhang JF
Mol Ther Nucleic Acids; 2018 Jun; 11():345-353. PubMed ID: 29858070
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of LINC-ROR in cancer cell lines and tissues.
Rezaei M; Emadi-Baygi M; Hoffmann MJ; Schulz WA; Nikpour P
Tumour Biol; 2016 Feb; 37(2):1763-9. PubMed ID: 26314857
[TBL] [Abstract][Full Text] [Related]
18. A review on the importance of LINC-ROR in human disorders.
Ghafouri-Fard S; Pourtavakoli A; Hussen BM; Taheri M; Kiani A
Pathol Res Pract; 2023 Apr; 244():154420. PubMed ID: 36989849
[TBL] [Abstract][Full Text] [Related]
19. Interaction between LncRNA-ROR and miR-145 contributes to epithelial-mesenchymal transition of ovarian cancer cells.
Li J; Zhang S; Wu L; Pei M
Gen Physiol Biophys; 2019 Nov; 38(6):461-471. PubMed ID: 31829305
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA ROR is a novel prognosis factor associated with non-small-cell lung cancer progression.
Qu CH; Sun QY; Zhang FM; Jia YM
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4087-4091. PubMed ID: 29028092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
